Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+4.50%
-3.98%
+0.20%
-0.73%
+9.23%
GEHC
GE HealthCare Technologie
$73.04
Login to display GE HealthCare Technologie (GEHC) recommendation from the last 90 days from financial news and social media. Strengths
Earnings are forecast to grow
Risk Analysis
Investors losing their confidence
Chart
$72.38 (+0.91%)
$75.2 (-2.87%)
$70.5 (+3.60%)
$91.62 (-20.28%)
GEHC has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
GEHC overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Momentum
Momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to grow
GEHC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
GEHC Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayGEHC Earnings
The TTM reflects 12-month period, providing review of GEHC financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is GEHC current stock price?
What are GEHC stock strengths?
What risks are associated with GEHC stock?
When is GEHC next earnings report?
What is GEHC market cap and volume?
What is GEHC's current Stock IQ?
Should I buy GEHC stock right now?
Is GEHC a Strong Buy right now?
What does a 'Strong Buy' rating mean for GEHC?
What does a 'Strong Sell' rating mean for GEHC?
What factors influence GEHC's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.50%
-3.98%
+0.20%
-0.73%
+9.23%
GEHC
GE HealthCare Technologie
Current Price
$73.04
Stock Insights
Strengths
Earnings are forecast to grow
Risk Analysis
Investors losing their confidence
Login to view GE HealthCare Technologie (GEHC) recommendation from the last 90 days from financial news and social media.
Chart
$72.38 (+0.91%)
$75.2 (-2.87%)
$70.5 (+3.60%)
$91.62 (-20.28%)
GEHC Analysts Opinion
GEHC Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Momentum
Momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to grow
GEHC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
GEHC Street view is extremely bullish and have positive views on the near-term outlook
GEHC has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayGEHC Earnings
The TTM data reflects the most recent 12-month period, providing overview of GEHC financial performance.
GEHC Financial Health
The company financial health has moderately improved over the past year
Financial Score
GEHC Latest Analysis
GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent. GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus PSMA PET imaging agent PYLARIFY for commercialization in Japan.
Fri Sep 26, 2025
Agree To Purchase GE HealthCare Technologies At $60 Earn 8% Annualized Using Options. Investors considering a purchase of GE HealthCare Technologies Inc (Symbol: GEHC) stock but tentative about paying the going market price of $69.88/share might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contra
Thu Sep 25, 2025
GE HealthCare Technologies declares $0.035 dividend.
Wed Sep 24, 2025
Lantheus and GE HealthCare sign licensing agreement for PYLARIFY in Japan.
Wed Sep 24, 2025
Lantheus And GE HealthCare Sign Licensing Deal For PYLARIFY In Japan . (RTTNews) - Lantheus Holdings Inc. (LNTH) and GE HealthCare (GEHC) announced an exclusive licensing agreement under which GE HealthCare will develop manufacture and commercialize Lantheus piflufolastat F18&mdash.marketed in the United States as PYLARIFY&mdash.in Japan for prostate cancer diagnosti
Wed Sep 24, 2025
Santé Ventures Announces Promotion of Michael Gutbrod PhD to Principal and Addition of Alana Horowitz PhD as Senior Associate. Promotion and team expansion highlight continued momentum for the firm and reinforce support for breakthrough innovations in biotechnology AUSTIN Texas Sept. 23 2025 /PRNewswire/ -- Santé Ventures (Santé) an early-stage healthcare and life sciences investment firm has announced the...
Tue Sep 23, 2025
GE Healthcare is said to be seeking a stake sale in China unit.
Thu Sep 18, 2025
GE Healthcare explores sale of stake in China unit - Bloomberg.
Thu Sep 18, 2025
Global Brain Imaging Devices Market is Projected to Grow at a CAGR of ~6% by 2032 | DelveInsight. Global Brain Imaging Devices Market is Projected to Grow at a CAGR of ~6% by 2032 |. DelveInsightThe brain imaging devices market is experiencing significant growth fueled by the increasing incidence of neurological conditions like brain tumors strokes Alzheimer'.s Parkinson'.s and epilepsy primarily attributed to aging populations and lifestyle influences. Additionally advancements in t
Thu Sep 11, 2025
GE HealthCare Technologies Inc. (GEHC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript.
Tue Sep 9, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GEHC Stock trends
GEHC Stock performance
GEHC Stock analysis
GEHC investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings